journal
Journals Current Opinion in Endocrinolo...

Current Opinion in Endocrinology, Diabetes, and Obesity

https://read.qxmd.com/read/38010050/bone-mass-accrual-in-children
#1
JOURNAL ARTICLE
Eugene Rodrick, Joseph M Kindler
PURPOSE OF REVIEW: Bone accrual during childhood and adolescence is critical for the attainment of peak bone mass and is a major contributing factor towards osteoporosis in later life. Bone mass accrual is influenced by nonmodifiable factors, such as genetics, sex, race, ethnicity, and puberty, as well as modifiable factors, such as physical activity and diet. Recent progress in bone imaging has allowed clinicians and researchers to better measure the morphology, density, and strength of the growing skeleton, thereby encompassing key characteristics of peak bone strength...
November 28, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/38010041/fibrous-dysplasia-in-children-and-its-management
#2
JOURNAL ARTICLE
Zubeyir Hasan Gun, Aleena Arif, Alison M Boyce
PURPOSE OF REVIEW: The purpose of this review is to provide a comprehensive overview into the diagnosis and management of fibrous dysplasia (FD) in children. RECENT FINDINGS: FD is a mosaic disorder arising from somatic Gαs variants, leading to impaired osteogenic cell differentiation. Fibro-osseous lesions expand during childhood and reach final disease burden in early adulthood. The mainstay of treatment focuses on surgical correction of skeletal deformities, physiatric care, and medical management of associated hyperfunctioning endocrinopathies...
November 28, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/38010030/legislation-medicine-and-politics-care-for-gender-diverse-youth
#3
JOURNAL ARTICLE
Stephanie Preston, Ximena Lopez
PURPOSE OF REVIEW: A recent increase in legislation in the United States prohibiting gender-affirming care (GAC) for transgender youth follows a wave of its politicization despite support from all pertinent mainstream medical associations. This review describes the standards of GAC for transgender youth, the origins of legislation prohibiting this care, a review of current legislation in the United States and a discussion on the impact on patients, providers, and the medical field. RECENT FINDINGS: A critical evaluation of historical parallels and current organizations supporting this legislation reveals it stems not from concerns within the medical field but from political and religious interests...
November 28, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37994661/multifactorial-chylomicronemia-syndrome
#4
JOURNAL ARTICLE
Alan Chait
PURPOSE OF REVIEW: The aim of this review was to understand the role of multifactorial chylomicronemia syndrome (MFCS) as a cause of severe hypertriglyceridemia; to distinguish it from other causes of severe hypertriglyceridemia; and to provide a rational approach to treatment. RECENT FINDINGS: There have been advances in understanding the genetic underpinning of MFCS, and a better appreciation as to how to differentiate it from the much rarer familial chylomicronemia syndrome, in which there are substantial differences in the approach to their treatment...
November 24, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37983310/health-economics-of-detection-and-treatment-of-children-with-familial-hypercholesterolemia-to-screen-or-not-to-screen-is-no-longer-the-question
#5
JOURNAL ARTICLE
Clara Marquina, Jedidiah I Morton, Zanfina Ademi
PURPOSE OF REVIEW: Heterozygous familial hypercholesterolemia (HeFH) is one of the most common monogenic disorders and is safely treatable with lipid-lowering medication. However, most individuals with HeFH remain untreated and undetected, especially in paediatric populations where the potential for long-term therapeutic benefit is higher. Here, we review the recent literature on health economic outcomes for the detection and management of FH in children. RECENT FINDINGS: A targeted literature review identified eight studies evaluating detection and management strategies for paediatric FH populations in the last 25 years...
November 21, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37902122/adherence-to-pharmacotherapy-sine-qua-non-for-reducing-cumulative-risk-of-premature-coronary-disease-in-familial-hypercholesterolemia
#6
JOURNAL ARTICLE
Jing Pang, Frank M Sanfilippo, Dick C Chan, Gerald F Watts
PURPOSE OF REVIEW: Familial hypercholesterolemia (FH) is a dominant and highly penetrant monogenic disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL)-cholesterol concentration and, if untreated, leads to atherosclerotic cardiovascular disease (ASCVD). The risk of ASCVD can be substantially reduced with lipid-lowering treatment (LLT). However, adherence to LLT remains a major challenge in FH patients and an under-recognized issue. We review several barriers to treatment adherence and implementation strategies for improving adherence in patients with FH...
October 31, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37882585/addressing-disparities-in-technology-use-among-patients-with-type-1-diabetes-a-review
#7
JOURNAL ARTICLE
Sarah Kanbour, Estelle Everett
PURPOSE OF REVIEW: The benefits of continuous glucose monitors (CGMs) and insulin pumps in the management of type 1 diabetes are widely recognized. However, glaring disparities in access exist, particularly in groups that stand to benefit significantly from diabetes technology use. We will review recent data describing drivers of these disparities and approaches to address the disparities. RECENT FINDINGS: Several qualitative studies were published in recent years that have investigated the drivers of disparities reported over the past decades...
October 26, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37820077/treating-obesity-in-type-1-diabetes-mellitus-review-of-efficacy-and-safety
#8
JOURNAL ARTICLE
Matthew Freeby, Kyrstin Lane
PURPOSE OF REVIEW: Obesity is an epidemic in the United States with serious concomitant co-morbid conditions; people living with type 1 diabetes mellitus (T1D) are not immune to the risk either. Weight gain in T1D is likely multifactorial, due to genetic, environmental and treatment-related factors. FDA-approved and other adjunctive weight loss therapies may benefit people living with T1D but there are risks to consider when providing recommendations or prescribing medications. RECENT FINDINGS: We performed a PubMed search of studies assessing clinical outcomes of both approved and off-label medications used in the treatment of type 1 diabetes...
October 12, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37800439/integrating-psychosocial-and-behavioral-interventions-into-type-1-diabetes-care
#9
JOURNAL ARTICLE
Elizabeth A Pyatak, Anya R Khurana
PURPOSE OF REVIEW: To identify recent literature evaluating the efficacy of psychosocial and behavioral interventions for people with type 1 diabetes (T1D). RECENT FINDINGS: Interventions generally produce benefits for psychosocial and behavioral outcomes, and some also positively impact glycemia. Addressing psychosocial concerns during routine provider visits had mixed results; some studies found that structured tools improved well being, while others found they could derail conversations, or contribute to worsening glycemia due to a lack of time to review medical concerns...
October 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37732930/assisted-reproductive-technology-outcomes-and-management-considerations-for-people-with-epilepsy
#10
JOURNAL ARTICLE
Regan J Lemley, Paula Emanuela Voinescu
PURPOSE OF REVIEW: Epilepsy is a common neurologic condition amongst people with reproductive capacity, and assisted reproductive technology (ART) is being increasingly utilized. A recent population-based study described favorable outcomes of ART in this population, but other work shows how fluctuating sex hormones may influence medication concentrations and seizures. RECENT FINDINGS: This review discusses hormonal influences on epilepsy and catamenial epilepsy, considerations regarding fertility in women with epilepsy, emerging ART outcomes, and management considerations for people with epilepsy undergoing ART...
September 22, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37646503/a-review-of-recent-evidence-on-androgen-abuse-from-interviews-with-users
#11
JOURNAL ARTICLE
Bonnie Grant, Suks Minhas, Channa N Jayasena
PURPOSE OF REVIEW: Androgens (also known as anabolic-androgenic steroids; AAS) are increasingly being abused worldwide to enhance body physique or athletic performance. Qualitative studies including interviews provide a wider understanding of androgen abuse and focus specific support needs to this group. This narrative review summarizes recent studies (2021-2023) using interviews with individuals abusing androgens. RECENT FINDINGS: Motivations for androgen abuse in men include desires to achieve certain physicality, enhance self-confidence and improve libido...
September 7, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37872797/editorial-introductions
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37678163/glucagon-like-peptide-1-receptor-agonists-and-safety-in-the-preconception-period
#13
REVIEW
Evelyn Minis, Fatima Cody Stanford, Shruthi Mahalingaiah
PURPOSE OF REVIEW: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are becoming increasingly popular for the treatment of type II diabetes and obesity. Body mass index (BMI) thresholds at in vitro fertilization (IVF) clinics may further drive the use of these medications before infertility treatment. However, most clinical guidance regarding optimal time to discontinue these medications prior to conception is based on animal data. The purpose of this review was to evaluate the literature for evidence-based guidance regarding the preconception use of GLP-1 RA...
December 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37578378/nutrition-and-thyroid-disease
#14
JOURNAL ARTICLE
Leonidas H Duntas
PURPOSE OF REVIEW: The aim of this review was to determine, based on the most recent findings, the involvement of trace elements and vitamins critical for thyroid function and combating thyroid disease. RECENT FINDINGS: Nutritional guidance is pivotal to reducing the risk of thyroid disease and to managing it when it arises, this meaning the prescription of diets rich in such micronutrients as iodine, selenium, iron, zinc, and vitamins B12, D3, and A. Most of the above micronutrients are good antioxidants, building up an anti-inflammatory profile, reducing thyroid autoantibodies and body fat, and improving thyroid function...
December 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37678177/updates-in-thyroid-healthcare-delivery-advancing-patient-centered-care
#15
JOURNAL ARTICLE
Maria Papaleontiou, Megan R Haymart
No abstract text is available yet for this article.
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37530703/molecular-testing-for-indeterminate-thyroid-nodules-past-present-and-future
#16
REVIEW
Rajam Raghunathan, Stephanie Smooke Praw, Masha Livhits
PURPOSE OF REVIEW: To examine the origin, current progress, and future directions of molecular testing in indeterminate Bethesda III and Bethesda IV thyroid nodules. RECENT FINDINGS: The diagnostic performance of current genomic tests shows improved benign call rates, specificity and positive-predictive values over prior test versions. The choice of test platform for clinical use should consider test performance, institutional rate of malignancy, nodule cytology and the potential for prognostication to help guide decision-making...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37417826/an-update-maternal-iodine-supplementation-thyroid-function-tests-and-child-neurodevelopmental-outcomes
#17
REVIEW
Caroline T Nguyen
PURPOSE OF REVIEW: The impact of maternal iodine supplementation (MIS) during pregnancy on thyroid function and child neurodevelopmental outcomes in areas of mild-to-moderate iodine deficiency (MMID) remains unclear. RECENT FINDINGS: Despite growing success of salt iodization programs, a 2022 meta-analysis found that 53% of pregnant patients worldwide continue to have insufficient iodine intake during pregnancy. A 2021 randomized controlled trial (RCT) found that MIS in women with mild iodine deficiency led to iodine sufficiency and positive effects on maternal thyroglobulin...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37410453/recent-advances-in-anaplastic-thyroid-cancer-management
#18
REVIEW
Sarah Hamidi, Anastasios Maniakas
PURPOSE OF REVIEW: To summarize recent developments in the diagnosis and management of patients with anaplastic thyroid cancer (ATC). RECENT FINDINGS: An updated edition of the Classification of Endocrine and Neuroendocrine Tumors was released by the World Health Organization (WHO), in which squamous cell carcinoma of the thyroid are now a subtype of ATC. Broader access to next generation sequencing has allowed better understanding of the molecular mechanisms driving ATC and improved prognostication...
October 1, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37603040/surveys-on-androgen-abuse-a-review-of-recent-research
#19
JOURNAL ARTICLE
Kyle T Ganson, Jason M Nagata
PURPOSE OF REVIEW: To summarize recent survey research on androgen abuse [i.e., anabolic-androgenic steroids (AAS)], including prevalence among international samples, risk factors for use, associated impairments of use, and treatment and interventions for abusers. RECENT FINDINGS: Recent research has documented the prevalence of androgens abuse remains most common among boys and men compared to girls and women, which was stable across nations. However, fewer studies have focused on population-based samples and instead focused on convenience or high-risk samples (i...
August 22, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/37603031/systematic-reviews-and-meta-analyses-on-androgen-administration-in-humans-an-umbrella-review
#20
JOURNAL ARTICLE
Razieh Chegeni, Ståle Pallesen, Hailemariam Weldemariam, Dominic Sagoe
PURPOSE OF REVIEW: The present umbrella review systematically searches and synthesizes recent (2021-2023) systematic reviews and meta-analyses (SRMA) on androgen administration in humans. RECENT FINDINGS: Results from 19 SRMA are synthesized. Four themes were identified: market for androgens, prevalence of androgen abuse, psychological effects of androgens, and clinical/therapeutic effects of androgens. One of three androgens on the illicit market are fake or substandard...
August 22, 2023: Current Opinion in Endocrinology, Diabetes, and Obesity
journal
journal
41662
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.